Skip to main content
Clinical Trials/ACTRN12622001160729
ACTRN12622001160729Terminated未知

Feasibility of delivering REmote Speech entrainment Therapy with people with long-term acquired and developmental communication disORdErs (RESTORE)

Kinephonics Trading Pty limited0 sites1 target enrollmentStarted: August 24, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Terminated
Sponsor
Enrollment
1

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • * Age 18 - 65 years
  • * Receiving National Disability Insurance Scheme (NDIS) funding
  • * Acquired or developmental communication disorders, caused by stroke, autism, cerebral palsy, intellectual or developmental disability, head injury, etc.
  • * Chronic communication disorder - >6 months post acquired injury
  • * English spoken as primary language
  • * Access to smartphone or tablet
  • * Provision of electronic informed consent

Exclusion Criteria

  • * Sensory loss (hearing/vision) preventing participation in communication assessments and treatments
  • * Acquired communication disorder diagnosed <6 months
  • * Progressive neurological disease
  • * Any other medical condition or disability, psychiatric, behavioural or drug-dependency problems, which are likely to influence the participant’s ability to cooperate or adhere to the protocol
  • * Participation in any other impairment-based therapy for communication disorders (including alternative therapies and clinical trials) during the study period
  • * Previous participation in Kinephonics intervention

Investigators

Sponsor
Kinephonics Trading Pty limited

Similar Trials